Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

AQSTAQST
Showing 8 of 16 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in AQUESTIVE THERAPEUTICS INC

Yes. Two Sigma holds 1,281,227 shares of AQST (Aquestive Therapeutics), worth $5.3M, as of its Q2 2026 13F filing. It increased the position by 141,823 shares (+12.5%) from Q1 2026. Two Sigma has held AQST since Q4 2025, across 3 quarterly 13F filings.

Current Value

$5.3M

Current Shares

1.3M

Total Value Change

+$4.7M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+12.4%
$5.3M0.0%$4.16
30
2026-Q1
Increased
1.1M
+199.0%
$4.7M0.0%$4.15
43
2025-Q4
New
381,120
-
$2.5M0.0%$6.46
36
2025-Q3
Exited
0
-100.0%
$00.0%$5.59
0
2025-Q2
Decreased
239,914
-35.5%
$794,1150.0%$3.31
0
2025-Q1
Increased
372,063
+111.5%
$1.1M0.0%$2.90
41
2024-Q4
Increased
175,952
+31.5%
$626,3890.0%$3.56
31
2024-Q3
Decreased
133,792
-2.1%
$666,2840.0%$4.98
0

Other major holders of AQST: BlackRock, Inc., RTW INVESTMENTS, LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used